Exact Sciences Corporation
EXAS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $10,350 | $13,327 | $8,731 | $13,336 |
| - Cash | $601 | $605 | $242 | $315 |
| + Debt | $2,755 | $2,555 | $2,447 | $2,382 |
| Enterprise Value | $12,504 | $15,276 | $10,936 | $15,403 |
| Revenue | $2,759 | $2,500 | $2,084 | $1,767 |
| % Growth | 10.4% | 19.9% | 17.9% | – |
| Gross Profit | $1,919 | $1,762 | $1,423 | $1,308 |
| % Margin | 69.5% | 70.5% | 68.3% | 74% |
| EBITDA | -$789 | $29 | -$421 | -$649 |
| % Margin | -28.6% | 1.2% | -20.2% | -36.7% |
| Net Income | -$1,029 | -$204 | -$624 | -$596 |
| % Margin | -37.3% | -8.2% | -29.9% | -33.7% |
| EPS Diluted | -5.59 | -1.13 | -3.54 | -3.48 |
| % Growth | -394.7% | 68.1% | -1.7% | – |
| Operating Cash Flow | $211 | $156 | -$224 | -$102 |
| Capital Expenditures | -$136 | -$124 | -$214 | -$136 |
| Free Cash Flow | $75 | $32 | -$438 | -$238 |